Lv71
4170 积分 2022-07-07 加入
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
3天前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (HARMONi-6): interim overall survival analysis of a randomised, double-blind, phase 3 trial in China
3天前
已关闭
First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations
5天前
已完结
PI3K Regulates Wild-type RAS Signaling to Confer Resistance to KRAS Inhibition
23天前
已完结
Daraxonrasib in Previously Treated Advanced RAS -Mutated Pancreatic Cancer
28天前
已完结
Ovarian cancer
1个月前
已关闭
Re-Evaluating Antibody–Drug Conjugate Linker Stability: Assessment, Interpretation, and Clinical Translation
1个月前
已完结
Ovarian cancer
1个月前
已完结
EGFR ’s Poor Sibling
1个月前
已完结
First-Line Zongertinib in Advanced HER2 -Mutant Non–Small-Cell Lung Cancer
1个月前
已完结
皖公网安备34019202002308
